Investing Profile

Carole Nuechterlein

VC
Photo of Carole Nuechterlein, Managing Partner at Roche Venture Fund
Your Intro Paths to Carole Nuechterlein

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Carole is a member of
University of Michigan Network
84 CONNECTIONS

Find Carole Nuechterlein on

cb
Current Investing Position
Roche Venture Fund Managing Partner
Investments On Record
9

Carole Nuechterlein's Investments On Record (5)

CompanyStageDateRound SizeTotal Raised
Enthera
Series AJan 2021$8M
$46M
Co-investors: Graziano Seghezzi (Soffinova Partners), Margarita Chavez (AbbVie Ventures)
Arch Oncology
Series AAug 2016$86M
$86M
Co-investors: Peter Moldt (Novo Ventures), John McKearn (RiverVest), Jill carroll (SR One)
AveXis
Series DSep 2015$65M
Series CJan 2015$10M
$75M
Co-investors: Jonathan Leff (Deerfield Management)
Lysosomal Therapeutics
Series AFeb 2015$20M
SeedMay 2014$5M
$25M
Co-investors: Bernard Davitian (Omega Funds), Clay Thorp (Hatteras Venture Partners), Bruce Booth (Atlas Venture), Reza Halse (RA Capital)
Alios BioPharma
Series BApr 2014$41M
Series AJun 2009$24M
Series AFeb 2009$8M
$74M
Co-investors: Heath Lukatch (Red Tree Venture Capital), Jens Eckstein (Apollo Health Ventures), Jack Nielsen (Vivo Capital)

Carole Nuechterlein's Experience

Head, Roche Venture Fund F.Hoffmann-La Roche2001 - Present
General Counsel SangStat1998 - 2001

Carole Nuechterlein's Education

University of Michigan JD